Skip to content

This content is in French.

ESMO Virtual Plenaries 2021

15 Juillet 2021 · 2 joursOnline, SwissOncologyEnglish
ESMO Virtual Plenaries 2021
Online

About this congress

KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab + chemotherapy vs. placebo + chemotherapy, followed by adjuvant pembrolizumab vs. placebo for early-stage TNBC

Videos from this congress

ESMO Virtual Plenaries 2021
Play the video · ESMO Virtual Plenaries 2021Free registration required to play

00:01:49